← Leaderboards
Nathaniel R. Landau
New York University School Of Medicine
$16,699,725
Attributed
$18,039,997
Total exposure
9
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.4M · FY2005–23$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$18,039,997 · 9
By mechanism
R01$11,323,590 · 5
DP1$4,237,500 · 1
R33$1,552,942 · 1
R21$925,965 · 2
Top collaborators
- Hans-Peter Kiem5 shared
- Scott G Kitchen5 shared
Most similar at New York University School Of Medicine
Same institution · by research overlap
- Michael L Dustin$32,535,535
Others in their field
Top investigators on “Virus Replication”
- Constance Ann Benson · University Of California, San Diego$187,673,896
- Judith S. Currier · University Of California Los Angeles$137,892,773
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$137,892,773
- Barton F Haynes · Duke University$110,672,613
- Charles M. Rice · Rockefeller University$53,754,576
- Rama Rao Amara · Emory University$53,347,944
Research focus
Virus ReplicationHiv-1ProteinsVirusCellsImmune ResponseVirionImmune SystemT-LymphocyteAntiviral AgentsSubfamily LentivirinaeGenesBasePlayPreventMediatingIn VivoInfectionMouse ModelBinding (Molecular Function)ResponseInsightSpecificityDendritic Cells
Grant awards (44)
Therapeutic Dendritic Cell Vaccine for HIV$847,500
DP1 · FY2023 · DA · contact PI
Therapeutic Dendritic Cell Vaccine for HIV$847,500
DP1 · FY2021 · DA · contact PI
Therapeutic Dendritic Cell Vaccine for HIV$847,500
DP1 · FY2020 · DA · contact PI
Dendritic Cell Vaccine for Controlling the Latent Reservoir$504,970
R33 · FY2020 · AI · contact PI
Therapeutic Dendritic Cell Vaccine for HIV$847,500
DP1 · FY2019 · DA · contact PI
Dendritic Cell Vaccine for Controlling the Latent Reservoir$506,210
R33 · FY2019 · AI · contact PI
Therapeutic Dendritic Cell Vaccine for HIV$847,500
DP1 · FY2018 · DA · contact PI
Dendritic Cell Vaccine for Controlling the Latent Reservoir$541,762
R33 · FY2018 · AI · contact PI
The Role of Vpr and Vpx in Lentivirus Replication$423,750
R01 · FY2017 · AI · contact PI
Dendritic Cell Vaccine for Controlling the Latent Reservoir$217,685
R21 · FY2017 · AI · contact PI
The Role of Vpr and Vpx in Lentivirus Replication$423,750
R01 · FY2016 · AI · contact PI
Dendritic Cell Vaccine for Controlling the Latent Reservoir$239,781
R21 · FY2016 · AI · contact PI
The Role of Vpr and Vpx in Lentivirus Replication$423,750
R01 · FY2015 · AI · contact PI
APOBEC3G/CEM15 Inhibition of Lentivirus Replication$418,275
R01 · FY2015 · AI · contact PI
The Role of Vpr and Vpx in Lentivirus Replication$423,750
R01 · FY2014 · AI · contact PI
APOBEC3G/CEM15 Inhibition of Lentivirus Replication$393,179
R01 · FY2013 · AI · contact PI
APOBEC3G/CEM15 Inhibition of Lentivirus Replication$266,963
R01 · FY2013 · AI · contact PI
APOBEC3G/CEM15 Inhibition of Lentivirus Replication$418,275
R01 · FY2012 · AI · contact PI
APOBEC3G/CEM15 Inhibition of Lentivirus Replication$418,275
R01 · FY2011 · AI · contact PI
Vpr Revisited$415,317
R01 · FY2011 · AI · contact PI
APOBEC3G/CEM15 Inhibition of Lentivirus Replication$422,500
R01 · FY2010 · AI · contact PI
Vpr Revisited$419,513
R01 · FY2010 · AI · contact PI
APOBEC3G/CEM15 Inhibition of Lentivirus Replication$168,784
R01 · FY2010 · AI · contact PI
Vpr Revisited$423,750
R01 · FY2009 · AI · contact PI
APOBEC3G/CEM15 Inhibition of Lentivirus Replication$70,416
R01 · FY2009 · AI · contact PI
Vpr Revisited$422,813
R01 · FY2008 · AI · contact PI
APOBEC3G/CEM15 Inhibition of Lentivirus Replication$354,743
R01 · FY2008 · AI · contact PI
Identification of Trim5alpha cofactors$124,649
R21 · FY2008 · AI · contact PI
APOBEC3G/CEM15 Inhibition of Lentivirus Replication$361,613
R01 · FY2007 · AI · contact PI
Identification of Trim5alpha cofactors$343,850
R21 · FY2007 · AI · contact PI
Murine Model for HIV-1 Replication$338,000
R01 · FY2006 · DA · contact PI
APOBEC3G/CEM15 Inhibition of Lentivirus Replication$260,146
R01 · FY2006 · AI · contact PI
APOBEC3G/CEM15 Inhibition of Lentivirus Replication$135,600
R01 · FY2006 · AI · contact PI
Murine Model for HIV-1 Replication$115,678
R01 · FY2006 · DA · contact PI
Murine Model for HIV-1 Replication$450,842
R01 · FY2005 · DA
APOBEC3G/CEM15 Inhibition of Lentivirus Replication$418,950
R01 · FY2005 · AI
Murine Model for HIV-1 Replication$559,001
R01 · FY2004 · DA
APOBEC3G/CEM15 Inhibition of Lentivirus Replication$418,950
R01 · FY2004 · AI
Murine Model for HIV-1 Replication$431,140
R01 · FY2002 · DA
Murine Model for HIV-1 Replication$83,582
R01 · FY2002 · DA
Murine Model for HIV-1 Replication$432,879
R01 · FY2001 · DA
HIV 1 CORECEPTORS IN TRANSMISSION AND PATHOGENESIS$360,293
R01 · FY2001 · AI
REGULATION OF CORECEPTOR TRANSCRIPTION$299,221
R01 · FY2001 · AI
REGULATION OF CORECEPTOR TRANSCRIPTION$349,892
R01 · FY2000 · AI